Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, et al
PMC12339632 Medical disclaimer: This article is for educational purposes and does not constitute medical advice
The safety of microdosing semaglutide (the active ingredient in Ozempic and Wegovy) remains a subject of debate
"By opening up about her own health, Serena is opening doors for millions of people who have felt shamed for needing support to lose weight," said Zach Reitano, co-founder and CEO of Ro
Additionally, although uncommon, reported cases of diabetic ketoacidosis (DKA) associated with GLP-1 RAs also warrant prompt treatment cessation (53)
For binge eating disorder with comorbid obesity, both approaches produced substantial improvements, with remission rates of 74.4% for behavioral weight loss and 66.5% for stepped care